Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-033048
Filing Date
2024-08-19
Accepted
2024-08-19 14:48:31
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1101870
2 ex31-1.htm EX-31.1 10991
3 ex31-2.htm EX-31.2 7593
4 ex32-1.htm EX-32.1 4467
5 ex32-2.htm EX-32.2 4584
  Complete submission text file 0001493152-24-033048.txt   5350493

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sigy-20240630.xsd EX-101.SCH 37677
7 XBRL CALCULATION FILE sigy-20240630_cal.xml EX-101.CAL 45164
8 XBRL DEFINITION FILE sigy-20240630_def.xml EX-101.DEF 135455
9 XBRL LABEL FILE sigy-20240630_lab.xml EX-101.LAB 345340
10 XBRL PRESENTATION FILE sigy-20240630_pre.xml EX-101.PRE 271616
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 826289
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 241219996
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)